Fig. 2

Study flowchart. Eligibility is assessed during the screening visit (patient and tumor characteristics) as well as the scout dose (lung shunting, extrahepatic depositions, etc.). Patients will be considered included once they received the actual treatment dose. The post-treatment follow-up visits serve to map toxicities, as well as to evaluate eligibility for resection. *The exact interval will be at 1.5, 3, 4.5, 6 and 9 months. The last follow-up will be at 9 months following treatment (if not converted) or 3 months after hepatectomy